Related Experiment Videos
Four human carcinoma cell lines with novel mutations in position 12 of c-K-ras oncogene
Abstract:
We have used synthetic oligonucleotides to probe for mutations affecting amino acid 12 of the c-K-ras gene in human cell line DNA. Of seven carcinoma cell lines tested, four were found to contain a mutation at this position. In each the nucleotide G was replaced with an A resulting in a Gly to Asp substitution in three cases (cell lines A427, A1165 and A1663) and Gly to Ser in the fourth (A549). Neither of these substitutions have been previously reported in either human tumor or human tumor-derived cell line DNA's. These results indicate that association between mutations involving position 12 of the human c-K-ras oncogene and carcinomas may be stronger than previously recognized.
Insights
Researchers identified new mutations in the c-K-ras gene ( Kirsten rat sarcoma viral oncogene homolog) in human carcinoma cell lines. These findings suggest a stronger link between c-K-ras mutations and carcinomas.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- The Kirsten rat sarcoma viral oncogene homolog (c-K-ras) is frequently implicated in human cancers.
- Mutations in the c-K-ras gene, particularly at amino acid position 12, are common drivers of tumorigenesis.
Purpose of the Study:
- To investigate mutations at amino acid 12 of the c-K-ras gene in human carcinoma cell lines.
- To identify novel c-K-ras mutations associated with specific carcinoma types.
Main Methods:
- Utilized synthetic oligonucleotides for mutation probing.
- Analyzed DNA from seven human carcinoma cell lines.
- Sequencing to identify nucleotide and amino acid substitutions.
Main Results:
- Four out of seven tested carcinoma cell lines harbored mutations at c-K-ras amino acid position 12.
- Identified G to A nucleotide substitutions leading to Glycine to Aspartic acid (Gly to Asp) or Glycine to Serine (Gly to Ser) amino acid changes.
- These specific Gly to Asp and Gly to Ser substitutions at position 12 were not previously reported in human tumor DNA.
Conclusions:
- The study identified previously unreported mutations in the c-K-ras oncogene in human carcinomas.
- These findings strengthen the association between c-K-ras mutations at position 12 and the development of carcinomas.